ADARx Pharmaceuticals, Inc. reports unregistered equity sale

ADARx Pharmaceuticals, Inc. filed an 8-K covering an unregistered sale of equity securities, charter, bylaw or fiscal-year changes, and other material corporate events. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.